This site is intended for healthcare professionals only
LoginRegister
USFDA nod to Caplin Steriles Linezolid Injection to treat serious bacterial infectionsHeart failure treatment: USFDA approves Caplin Steriles Milrinone Lactate in 5% Dextrose Injection,...
Lupin secures SBTi validation for emission reduction targetsLupin wins USFDA nod for Risperidone for extended-release injectable suspension for schizophrenia
Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority NodHealth Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central...
Unichem Pharma USA recalls one lot of Cyclobenzaprine Hydrochloride Tablets 10 mg over mislabelingUnichem Pharma USA recalls one lot of Cyclobenzaprine Hydrochloride Tablets 10 mg over mislabeling
Sun Pharma Names Sana Shaikh as Head of MarketingSun Pharma Gets CDSCO Panel Nod to Manufacture, Market Enzalutamide for Prostate Cancer
India MedTech Expo 2025: DoP to hold second edition from 4th to 6th SeptemberIndia MedTech Expo 2025: DoP to hold second edition from 4th to 6th September
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentThermo Fisher Scientific concludes acquisition of Sanofi New Jersey site
NPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, CefiximeNPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, Cefixime
Brain Cancer Drug Found in Wrong Packaging at Kerala RCC, SHRC Steps InHealth Ministry Drafts Rule Change to Halve Drug Trial Approval Time from 90 to 45 Days
Karnataka AYUSH Dept Under Fire: MLA Alleges Corrupt Procurement, Expired Drugs Sent to Mangaluru HospitalTelegram Trading Scam Tricks Kochi Pharma Firm Owner Into Losing Rs 25 Crore
India targets new markets for pharma export growth amid US tariffs concernsIndia targets new markets for pharma export growth amid US tariffs concerns
CDSCO Panel Rejects Hetero Labs Plea for Lenacapavir Approval Without Local TrialsHetero Biopharma Gets CDSCO Panel Nod for Phase IV Trial of Denosumab Injection in Cancer Patients
X